Delivery Order SPE2DB22D2006-SPE2DB25FW0FF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $25,275.80 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100 units, with a ceiling value of $19,475.42. The contract employs firm fixed price pricing and has an ultimate completion date of November 25, 2025. This award is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $31,675.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count). This contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a pharmaceutical supply delivery under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,908.40 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The contract specifies performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.30 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial pharmaceutical is being procured through the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,492.71 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order utilizes firm fixed-price terms and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW0FFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, delivered through competitive delivery orders with firm fixed pricing. As a prime contractor on the DLA Troop Support Medical IDC, AmerisourceBergen supplies brand-name and generic medications, vaccines, and specialized medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Atovaquone-Proguanil antimalarial medication supplied under this delivery order is typical of the company's pharmaceutical offerings for military and federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/23/25 |